Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SCZM | CMP |
|---|---|---|
| Price | $8.45 | $22.57 |
| Change today | ▼ 5.69% | ▼ 0.57% |
| Market cap | $785.77M | $947.51M |
| Return, 3 months | +26.7% | -22.3% |
| Return, year to date | -12.5% | +14.9% |
| Return, 1 year | +15.4% | +16.5% |
| P/E (TTM) | 18.8 | 53.7 |
| P/B | 3.7 | 3.6 |
| P/E percentile vs own 5y | 65th | 82nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +54.8% | +0.3% |
| Net profit growth (YoY) | -90.4% | +66.5% |
| Gross margin | 35.5% | 17.2% |
| Operating margin | 28.0% | 8.9% |
| Net margin | 10.0% | 1.4% |
| Return on equity | 22.5% | 7.0% |
| Analyst target vs. price | +100.8% | +24.1% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 43 | 38 |
| 30-day volatility | 74.7% | 25.5% |
| Max drawdown, 1 year | -63.2% | -34.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
